BSLN

AcronymDefinition
BSLNBalai Seni Lukis Negara (Malay: National Art Gallery; Kuala Lumpur, Malaysia)
BSLNBedford-Sackville Literacy Network (Canada)
References in periodicals archive ?
is headquartered in Basel, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN).
The fruits of the BSLN commitment include summer FreedOm Schools that provide academic, cultural, and enrichment programs for children and leadership development training seminars for young adults.
Basilea Pharmaceutica is headquartered in Basel, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN).
Basilea Pharmaceutica Ltd (SWX: BSLN) has entered into a licence agreement with ArQule (NASDAQ: ARQL) for its oncology drug candidate ARQ 087 (derazantinib), the company announced on Tuesday.
Adesh Kaul has joined Basilea Pharmaceutica Ltd's (SWX: BSLN) Management Committee as chief corporate development officer, effective today, the company disclosed on Thursday.
(SIX: BSLN) to develop and commercialise derazantinibin globally, excluding the People's Republic of China, Hong Kong, Macau and Taiwan, where Sinovant Sciences Ltd., a Roivant Sciences Ltd.
Basilea Pharmaceutica Ltd (SWX: BSLN) has started enrolling participants in the first of its two clinical Phase 3 registration studies of the antibiotic ceftobiprole, the company announced on Friday.
Basilea Pharmaceutica Ltd's (SWX: BSLN) chief executive officer Ronald Scott is to retire after working there for 18 years, the company announced on Wednesday.
Basilea Pharmaceutica Ltd (SWX: BSLN) has completed the extension of its licence agreement with Pfizer Inc (NYSE: PFE) for its antifungal Cresemba (isavuconazole) to include China (with Hong Kong and Macao), as well as 16 other countries in the Asia Pacific region, the Switzerland-based company announced on Wednesday.
Basilea Pharmaceutia International Ltd (SWX: BSLN) has extended its existing licensing agreement with Pfizer (NYSE: PFE) for the antifungal Cresemba (isavuconazole), the Swiss company announced on Friday.
Basilea Pharmaceutica Ltd's (SWX: BSLN) licensing partner Pfizer (NYSE: PFE) has recently launched the antifungal drug Cresemba (isavuconazole) in Spain, the Switzerland-based biopharmaceutical company said on Thursday.
After seven years with the company, Professor Achim Kaufhold will retire as chief medical officer from Basilea Pharmaceutical Ltd (SWX: BSLN), the company disclosed on Tuesday.